Skip to main content

Table 3 Comparisons of QOL at the baseline and 2 weeks post-RT between the two groups (n = 178)

From: The benefits of psychosocial interventions for cancer patients undergoing radiotherapy

EORTC QLQ-C30 subscales Item Baseline 2 weeks post-RT
   IG (n = 89) CON (n = 89)    IG (n = 89) CON (n = 89)   
   Mean(SD) Mean(SD) t value p value Mean(SD) Mean(SD) t value p value*
Functioning scales          
Physical functioning PF 1-5 77.23(10.19) 78.91(10.81) −1.067 0.288 79.70(9.80) 75.36(9.71) 2.970 0.003
Role functioning RF 6,7 59.55(24.48) 58.28(24.49) 0.347 0.729 59.18(24.23) 57.45(21.01) 0.507 0.613
Emotional functioning EF 21-24 72.57(12.51) 70.77(14.71) 0.874 0.383 74.18(11.43) 66.03(14.00) 4.251 <0.001
Cognitive functioning CF 20,25 80.71(11.48) 81.27(11.46) −0.327 0.744 81.09(12.36) 78.58(10.01) 1.489 0.138
Social functioning SF 26,27 75.00(13.82) 73.43(12.31) 0.802 0.424 74.35(10.67) 71.33(11.88) 1.782 0.076
Global health status QL 29,30 61.31(13.23) 58.43(12.78) 1.48 0.141 58.80(12.20) 51.12(12.82) 4.092 <0.001
Symptom scales and/or items          
Fatigue FA 10,12,18 28.05(14.75) 28.63(13.38) −0.276 0.783 29.20(11.86) 32.93(13.78) −1.938 0.054
Nausea/vomiting NV 14,15 11.05(11.50) 9.74(9.99) 0.812 0.418 14.61(12.26) 15.92(10.93) −0.753 0.452
Pain PA 9,19 31.46(13.86) 30.52(14.70) 0.437 0.662 28.84(15.64) 30.90(16.77) −0.847 0.398
Dyspnea DY 8 12.36(16.19) 14.79(16.56) −0.992 0.323 11.98(16.08) 12.36(16.95) −0.151 0.880
Insomnia SL 11 29.21(22.37) 30.71(21.45) −0.456 0.649 27.71(20.25) 34.08(20.71) −2.074 0.040
Appetite loss AP 13 23.03(22.96) 25.09(22.63) −0.603 0.547 26.78(21.26) 28.84(23.13) −0.618 0.537
Constipation CO 16 16.85(20.18) 16.10(20.17) 0.248 0.805 18.73(19.43) 20.97(19.71) −0.766 0.445
Diarrhea DI 17 10.86(19.32) 9.36(15.88) 0.565 0.573 13.11(17.13) 12.36(18.38) 0.281 0.779
Financial difficulties FI 28 62.17(29.38) 61.42(29.26) 0.170 0.865 68.17(30.11) 67.04(28.65) 0.255 0.799
  1. Abbreviations: IG intervention group, CON control group, SD standard deviation, RT radiation treatment; EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 items.
  2. * p values in boldface indicate statistically significant difference.